The enigma of squamous cell carcinoma of the colon: a case report and review

Adjuvant chemotherapy may benefit select high-risk stage II patients with primary colonic SCC with high-risk features such as pT4 tumor penetration. as exemplified in this case. Consistent data collection, collaboration, and molecular characterization are essential to establish evidence-based treatment strategies for this uncommon malignancy.